Apparent absence of famotidine-antipsychotic drug interactions in patients with chronic schizophrenia.
作者信息
Prell G D, Rosse R B, Deutsch S I
出版信息
J Psychiatry Neurosci. 1996 Jan;21(1):61-2.
Abstract
摘要
相似文献
1
Apparent absence of famotidine-antipsychotic drug interactions in patients with chronic schizophrenia.慢性精神分裂症患者中未发现法莫替丁与抗精神病药物之间存在明显相互作用。
J Psychiatry Neurosci. 1996 Jan;21(1):61-2.
2
Famotidine augmentation in schizophrenia: hope or hype?法莫替丁辅助治疗精神分裂症：希望还是炒作？
J Clin Psychiatry. 2013 Sep;74(9):e855-8. doi: 10.4088/JCP.13f08707.
3
Famotidine adjunctive pharmacotherapy for schizophrenia: preliminary data.法莫替丁辅助药物治疗精神分裂症：初步数据。
Clin Neuropharmacol. 1993 Dec;16(6):518-24.
4
Pharmacokinetics and pharmacodynamics of famotidine in infants.
J Clin Pharmacol. 1998 Dec;38(12):1089-95.
5
Pharmacokinetics and pharmacodynamics of famotidine in children.法莫替丁在儿童中的药代动力学和药效学
J Clin Pharmacol. 1996 Jan;36(1):48-54. doi: 10.1002/j.1552-4604.1996.tb04151.x.
6
[Famotidine--a new histamine H2 antagonist].法莫替丁——一种新型组胺H2拮抗剂
Tidsskr Nor Laegeforen. 1990 Oct 10;110(24):3129-30.
7
Effects of three H2-receptor antagonists (cimetidine, famotidine, ranitidine) on serum gastrin level.三种H2受体拮抗剂（西咪替丁、法莫替丁、雷尼替丁）对血清胃泌素水平的影响。
Int J Clin Pharmacol Res. 2002;22(2):29-35.
8
Famotidine in the management of schizophrenia.法莫替丁在精神分裂症治疗中的应用
Ann Pharmacother. 1999 Jun;33(6):742-7. doi: 10.1345/aph.18262.
9
Pharmacokinetics and efficacy of intravenous famotidine in adult cattle.成年牛静脉注射法莫替丁的药代动力学及疗效
J Vet Intern Med. 2018 May;32(3):1283-1289. doi: 10.1111/jvim.15080. Epub 2018 Mar 23.
10
Famotidine-associated delirium. A series of six cases.法莫替丁相关的谵妄。六例病例系列。
Psychosomatics. 1996 Jul-Aug;37(4):349-55. doi: 10.1016/S0033-3182(96)71548-7.
本文引用的文献
1
Famotidine adjunctive pharmacotherapy for schizophrenia: preliminary data.法莫替丁辅助药物治疗精神分裂症：初步数据。
Clin Neuropharmacol. 1993 Dec;16(6):518-24.
2
Famotidine adjunctive pharmacotherapy of schizophrenia: a case report.法莫替丁辅助治疗精神分裂症：一例报告。
Clin Neuropharmacol. 1995 Aug;18(4):369-74. doi: 10.1097/00002826-199508000-00009.
3
Famotidine as an adjunct treatment of resistant schizophrenia.法莫替丁作为难治性精神分裂症的辅助治疗药物。
J Psychiatry Neurosci. 1994 Mar;19(2):145-50.
4
Loss of striatal histamine H2 receptors in Huntington's chorea but not in Parkinson's disease: comparison with animal models.亨廷顿舞蹈病而非帕金森病中纹状体组胺H2受体的丧失：与动物模型的比较
Synapse. 1993 Nov;15(3):209-20. doi: 10.1002/syn.890150306.
5
An open-label study of famotidine as a treatment for schizophrenia.一项关于法莫替丁治疗精神分裂症的开放标签研究。
J Psychiatry Neurosci. 1995 May;20(3):239-40.
6
Histamine metabolites in cerebrospinal fluid of patients with chronic schizophrenia: their relationships to levels of other aminergic transmitters and ratings of symptoms.慢性精神分裂症患者脑脊液中的组胺代谢产物：它们与其他胺能递质水平及症状评分的关系
Schizophr Res. 1995 Jan;14(2):93-104. doi: 10.1016/0920-9964(94)00034-6.
7
Famotidine. An updated review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in peptic ulcer disease and other allied diseases.法莫替丁。对其药效学和药代动力学特性以及在消化性溃疡疾病和其他相关疾病中的治疗用途的最新综述。
Drugs. 1989 Oct;38(4):551-90. doi: 10.2165/00003495-198938040-00005.
8
Effect of famotidine on deficit symptoms of schizophrenia.法莫替丁对精神分裂症缺陷症状的影响。
Lancet. 1990 Jun 2;335(8701):1351-2. doi: 10.1016/0140-6736(90)91237-5.
9
Decreased histamine H1 receptors in the frontal cortex of brains from patients with chronic schizophrenia.
Biol Psychiatry. 1991 Aug 15;30(4):349-56. doi: 10.1016/0006-3223(91)90290-3.
Zotero 插件